Kala Pharmaceuticals, Inc.

$KALA is the biggest laggard in the Prism MarketView Pharmaceuticals index, yesterday they disclosed the immediate resignation of its Chief Executive Officer, Mark Iwicki

Share this article:

About the Author:

Kala Pharmaceuticals, Inc.

Joey Ramson

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup